Intrinsic Value of S&P & Nasdaq Contact Us

Lords & Company Worldwide Holdings Inc. LRDSF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
7/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Lords & Company Worldwide Holdings Inc. (LRDSF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 7/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $3M, +0%/yr average growth. Net income is $1M (loss), growing at -177.7%/yr. Net profit margin is -51.6% (negative). Gross margin is 8.6% (+0 pp trend).

Balance sheet: total debt is $0 with negative equity of -$815,792 — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.33 (tight liquidity). Debt-to-assets is 0%. Total assets: $410,899.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 0/100 (Fail), Moat 11/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

LRDSF SharesGrow Score Overview

12/100
SharesGrow Score
Weak fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 11/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range0.0002-0.0009
Volume17.51K
Avg Volume (30D)9.56K
Market Cap$13.35K
Beta (1Y)1.09
Share Statistics
EPS (TTM)-0.07
Shares Outstanding$21.03M
IPO Date2020-11-16
CEOChristopher Farnworth
Financial Highlights & Ratios
Revenue (TTM)$2.84M
Gross Profit$245.43K
EBITDA$-1.45M
Net Income$-1.47M
Operating Income$-1.09M
Total Cash$154.02K
Net Debt$-154.02K
Total Assets$410.9K
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA54404Q2009

Price Chart

LRDSF
Lords & Company Worldwide Holdings Inc.  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.00
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message